← All organizations

Rheacell GmbH & Co. KG

For profitWebsite ↗

Also known as: RHEACELL GmbH & Co. KG

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 30, 2024

Timeline

2010s

Jun 1, 2012
Rheacell GmbH & Co. KG— Founded

Drugs by trial phase (7 distinct, 11 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT06489028OfficialPhase 3Sep 30, 2024
NCT06489028Lead sponsorPhase 3Sep 30, 2024
NCT05838092Lead sponsorPhase 3Oct 18, 2023
NCT05464381Lead sponsorPhase 3Dec 31, 2022
NCT04971161Lead sponsorPhase 2Aug 18, 2021
NCT03860155Lead sponsorPhase 1/Phase 2Apr 30, 2019
NCT03549299Lead sponsorPhase 1/Phase 2Nov 30, 2018
NCT03529877Lead sponsorPhase 1/Phase 2Oct 31, 2018
NCT03339973Lead sponsorPhase 1/Phase 2Mar 5, 2018
NCT03267784Lead sponsorPhase 1/Phase 2Nov 21, 2017
NCT03257098Lead sponsorPhase 1/Phase 2Nov 16, 2017
NCT02742844Lead sponsorPhase 1/Phase 2Aug 1, 2016

Details

Founded: Heidelberg, DE Jun 1, 2012
Last known activity: Sep 30, 2024